Off-label medication use

Jennifer H. Cao

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Off-label medication use is a prominent feature in the treatment and management of ophthalmology patients, and uveitic glaucoma is no exception. The United States Food and Drug Administration recommend that physicians use legally-available drugs according to their best knowledge and judgment. The off-label use of non-approved medications requires responsibility on the part of the prescribing physician to be well-informed about the product and to have a scientific rationale (backed by published literature) for its use. In some instances, the use of off-label medications has been adopted as “standard of care," despite lack of FDA approval. The classic example is the pediatric use of nearly everything in ophthalmology, from drops, to sutures, to surgical implants, all of which are used off-label. The same can be said for most anti-inflammatory medications considered as standard of care for uveitis, as very few currently hold explicit approval for use in the indication of uveitis.

Original languageEnglish (US)
Title of host publicationUveitic Glaucoma
PublisherNova Science Publishers, Inc.
Pages177-180
Number of pages4
ISBN (Electronic)9781634846332
ISBN (Print)9781634846141
StatePublished - Jan 1 2016

Fingerprint

Off-Label Use
Uveitis
Ophthalmology
Standard of Care
Physicians
United States Food and Drug Administration
Glaucoma
Sutures
Anti-Inflammatory Agents
Pediatrics
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cao, J. H. (2016). Off-label medication use. In Uveitic Glaucoma (pp. 177-180). Nova Science Publishers, Inc..

Off-label medication use. / Cao, Jennifer H.

Uveitic Glaucoma. Nova Science Publishers, Inc., 2016. p. 177-180.

Research output: Chapter in Book/Report/Conference proceedingChapter

Cao, JH 2016, Off-label medication use. in Uveitic Glaucoma. Nova Science Publishers, Inc., pp. 177-180.
Cao JH. Off-label medication use. In Uveitic Glaucoma. Nova Science Publishers, Inc. 2016. p. 177-180
Cao, Jennifer H. / Off-label medication use. Uveitic Glaucoma. Nova Science Publishers, Inc., 2016. pp. 177-180
@inbook{f9c418b9db6148d59fa5346d7631867b,
title = "Off-label medication use",
abstract = "Off-label medication use is a prominent feature in the treatment and management of ophthalmology patients, and uveitic glaucoma is no exception. The United States Food and Drug Administration recommend that physicians use legally-available drugs according to their best knowledge and judgment. The off-label use of non-approved medications requires responsibility on the part of the prescribing physician to be well-informed about the product and to have a scientific rationale (backed by published literature) for its use. In some instances, the use of off-label medications has been adopted as “standard of care,{"} despite lack of FDA approval. The classic example is the pediatric use of nearly everything in ophthalmology, from drops, to sutures, to surgical implants, all of which are used off-label. The same can be said for most anti-inflammatory medications considered as standard of care for uveitis, as very few currently hold explicit approval for use in the indication of uveitis.",
author = "Cao, {Jennifer H.}",
year = "2016",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781634846141",
pages = "177--180",
booktitle = "Uveitic Glaucoma",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Off-label medication use

AU - Cao, Jennifer H.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Off-label medication use is a prominent feature in the treatment and management of ophthalmology patients, and uveitic glaucoma is no exception. The United States Food and Drug Administration recommend that physicians use legally-available drugs according to their best knowledge and judgment. The off-label use of non-approved medications requires responsibility on the part of the prescribing physician to be well-informed about the product and to have a scientific rationale (backed by published literature) for its use. In some instances, the use of off-label medications has been adopted as “standard of care," despite lack of FDA approval. The classic example is the pediatric use of nearly everything in ophthalmology, from drops, to sutures, to surgical implants, all of which are used off-label. The same can be said for most anti-inflammatory medications considered as standard of care for uveitis, as very few currently hold explicit approval for use in the indication of uveitis.

AB - Off-label medication use is a prominent feature in the treatment and management of ophthalmology patients, and uveitic glaucoma is no exception. The United States Food and Drug Administration recommend that physicians use legally-available drugs according to their best knowledge and judgment. The off-label use of non-approved medications requires responsibility on the part of the prescribing physician to be well-informed about the product and to have a scientific rationale (backed by published literature) for its use. In some instances, the use of off-label medications has been adopted as “standard of care," despite lack of FDA approval. The classic example is the pediatric use of nearly everything in ophthalmology, from drops, to sutures, to surgical implants, all of which are used off-label. The same can be said for most anti-inflammatory medications considered as standard of care for uveitis, as very few currently hold explicit approval for use in the indication of uveitis.

UR - http://www.scopus.com/inward/record.url?scp=85019918036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019918036&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85019918036

SN - 9781634846141

SP - 177

EP - 180

BT - Uveitic Glaucoma

PB - Nova Science Publishers, Inc.

ER -